comprehensive -WSS

comprehensive

author：explore 2025-10-02 22:28:23 - browse：48

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Indictment alleges Trump's ex

WSS

Treatments for cramps don't cut it. Why aren't there better options?

The most pressing bird flu mysteries scientists want answered

Structure Therapeutics oral GLP

The most pressing bird flu mysteries scientists want answered

Illumina board agrees to spin off Grail, as divestment plans proceed

CMS got Medicare Advantage quality rating wrong, judge rules

leisure time

comprehensive

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Idaho college killings prosecutors challenge defense's grand jury claims

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

New air purifier tech could be key to improving indoor air quality

CMS got Medicare Advantage quality rating wrong, judge rules

Malaria cases in Florida and Texas: Here’s what you need to know

Stopping antidepressants leads to symptoms for 1 in 6 patients

Anesthesiologist group: stop taking Ozempic before surgery

Treatments for cramps don't cut it. Why aren't there better options?

hotspot

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

Mark Cuban is blaming the wrong people for high drug costs

Medicare Advantage's lean provider networks lead CMS complaints

Surge in Apellis stock fueled by confidence in safety of its eye drug

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Fight over Supreme Court dialysis ruling puts kidney patients at risk

knowledge

focus

leisure time

explore